106 related articles for article (PubMed ID: 15852412)
1. Characterization of antiproliferative and cytotoxic properties of the HSV-1 immediate-early ICPo protein.
Cuchet D; Ferrera R; Lomonte P; Epstein AL
J Gene Med; 2005 Sep; 7(9):1187-99. PubMed ID: 15852412
[TBL] [Abstract][Full Text] [Related]
2. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
Härle P; Sainz B; Carr DJ; Halford WP
Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
[TBL] [Abstract][Full Text] [Related]
3. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.
Miller CS; Danaher RJ; Jacob RJ
J Virol; 2006 Apr; 80(7):3360-8. PubMed ID: 16537603
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.
Boutell C; Canning M; Orr A; Everett RD
J Virol; 2005 Oct; 79(19):12342-54. PubMed ID: 16160161
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression.
Preston CM; Mabbs R; Nicholl MJ
Virology; 1997 Mar; 229(1):228-39. PubMed ID: 9123865
[TBL] [Abstract][Full Text] [Related]
6. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).
Maul GG; Guldner HH; Spivack JG
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2679-90. PubMed ID: 8277273
[TBL] [Abstract][Full Text] [Related]
7. ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.
Halford WP; Schaffer PA
J Virol; 2001 Apr; 75(7):3240-9. PubMed ID: 11238850
[TBL] [Abstract][Full Text] [Related]
8. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection.
Everett RD
J Virol; 2004 Sep; 78(18):9599-604. PubMed ID: 15331692
[TBL] [Abstract][Full Text] [Related]
10. Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release.
Ralph WM; Cabatingan MS; Schaffer PA
J Virol; 1994 Nov; 68(11):6871-82. PubMed ID: 7933067
[TBL] [Abstract][Full Text] [Related]
11. A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1.
Cai W; Schaffer PA
J Virol; 1991 Aug; 65(8):4078-90. PubMed ID: 1649316
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the herpes simplex virus tegument protein VP22 has no effect on incorporation of VP22 into the virus but is involved in optimal expression and virion packaging of ICP0.
Potel C; Elliott G
J Virol; 2005 Nov; 79(22):14057-68. PubMed ID: 16254340
[TBL] [Abstract][Full Text] [Related]
13. The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0.
Davido DJ; Von Zagorski WF; Maul GG; Schaffer PA
J Virol; 2003 Dec; 77(23):12603-16. PubMed ID: 14610183
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function.
Davido DJ; von Zagorski WF; Lane WS; Schaffer PA
J Virol; 2005 Jan; 79(2):1232-43. PubMed ID: 15613350
[TBL] [Abstract][Full Text] [Related]
15. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
16. ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.
Liu M; Schmidt EE; Halford WP
PLoS One; 2010 Jun; 5(6):e10975. PubMed ID: 20544015
[TBL] [Abstract][Full Text] [Related]
17. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1.
Ferrera R; Cuchet D; Zaupa C; Revol-Guyot V; Ovize M; Epstein AL
J Mol Cell Cardiol; 2005 Jan; 38(1):219-23. PubMed ID: 15623439
[TBL] [Abstract][Full Text] [Related]
18. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
19. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0.
Fowler AM; Shinogle HE; Davido DJ
Antiviral Res; 2015 Aug; 120():1-6. PubMed ID: 25936965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
